TF inhibitors (Tularik/Merck & Co)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameTF inhibitors (Tularik/Merck & Co)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRespiratory Syncytial Virus InfectionsHepatitis CPapillomavirus Infections +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTularik Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co IncTularik Inc
Active IndicationsN/A
Inactive IndicationsRespiratory Syncytial Virus InfectionsHepatitis CPapillomavirus Infections +[7] 

Other Information

ATC CodeN/A
Related LinksN/A